Investigator Initiated Studies

At Genentech, rigorous and groundbreaking science with real human impact is at the core of what we do. We apply this science in our R&D activities to discover and develop potential new medicines with the goal of becoming first-in-class or best-in-class therapeutics. Investigator initiated clinical studies play a valuable role in our overall R&D approach.

Important Notice

Any IIS applications that are in process as of November 15, 2018 will continue through the classic IIS Portal system.

Click here to access the classic IIS Portal.

Do you have an idea for an Investigator Initiated Study (IIS)? We welcome unsolicited proposals from qualified sponsors with promising ideas in our areas of strategic interest. Well-written, scientifically sound studies that enhance the understanding of our medicines, improve patient care, and spark new ideas for disease-related research will be considered. Our medical science personnel are available to guide you through each step in the process, from concept pre-approval to submitting the final budget and protocol.


Areas of Strategic Interest

We welcome unsolicited research proposals from qualified sponsors with promising ideas in our areas of strategic interest. You can view more details by clicking on our products below.

Hemophilia

Immunology

Neuroscience

Oncology

Opthalmology

Respiratory

Thrombolytics

Virology